Investing
1575 Articles
Live Updates Booking Gets a Good Review Nov 13, 2025 at 12:05 PM EST Wedbush analyst Scott Devitt upgraded travel…
The best thing Disney’s new CEO can do is put the company on the market as soon as possible. On-again,…
Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.
Disney is America’s worst-run entertainment giant. Efforts to keep the company afloat have not impressed investors, as its stock chart…
Our top personal finance-related articles today. Your wallet will thank you later.